Table 1.

Distribution of baseline characteristics for cases and controls

Cases (n = 415)Controls (n = 848)P
C5, μg/mL 60.4 58.2 .003 
Age in years, y 60 ± 14 60 ± 14 .999 
Male sex 48.4 (201) 46.7 (396) .603 
BMI, kg/m2 27.2 ± 4.5 26.1 ± 4.1 <.001 
Smoking 29.5 (123) 32.0 (271) .441 
Diabetes* 4.1 (17) 3.9 (33) .995 
CVD* 15.7 (65) 15.6 (132) .999 
Cancer* 6.2 (26) 3.7 (31) .051 
hsCRP, mg/L 1.7 ± 1.4 1.6 ± 1.4 .077 
White blood cell count, ×109/L 7.2 ± 2.9 7.0 ± 1.8 .177 
Platelet count, ×109/L 247 ± 57 244 ± 53 .336 
Cases (n = 415)Controls (n = 848)P
C5, μg/mL 60.4 58.2 .003 
Age in years, y 60 ± 14 60 ± 14 .999 
Male sex 48.4 (201) 46.7 (396) .603 
BMI, kg/m2 27.2 ± 4.5 26.1 ± 4.1 <.001 
Smoking 29.5 (123) 32.0 (271) .441 
Diabetes* 4.1 (17) 3.9 (33) .995 
CVD* 15.7 (65) 15.6 (132) .999 
Cancer* 6.2 (26) 3.7 (31) .051 
hsCRP, mg/L 1.7 ± 1.4 1.6 ± 1.4 .077 
White blood cell count, ×109/L 7.2 ± 2.9 7.0 ± 1.8 .177 
Platelet count, ×109/L 247 ± 57 244 ± 53 .336 

Data are means ± SD or percentages with number of cases or controls in parentheses.

hsCRP, high-sensitivity CRP.

*

Self-reported history of diabetes, cancer, or CVD (myocardial infarction, angina pectoris, or stroke) at baseline.

Close Modal

or Create an Account

Close Modal
Close Modal